Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.

被引：0
|
作者：
Hyldstrup, L
Jorgensen, JT
Gaich, G
机构：
[1] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Copenhagen, Denmark
[2] Pronosco AS, Vedbaek, Denmark
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
BONE | 2001年 / 28卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [1] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804
  • [2] Effects of LY333334 [recombinant parathyroid hormone (1-34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography.
    Zanchetta, JR
    Bogado, C
    Ferretti, JL
    Wang, O
    Sato, M
    Gaich, GA
    [J]. BONE, 2001, 28 (05) : S86 - S86
  • [3] Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits
    Hirano, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (04) : 536 - 545
  • [4] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [5] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Stancill, MW
    Hock, JM
    Jerome, CP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763
  • [6] Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. BONE, 2001, 28 (05) : 538 - 547
  • [7] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).
    Black, EC
    Frolik, CA
    Hock, JM
    Cain, RL
    Chandrasekhar, S
    Harvey, AK
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370
  • [8] A randomized controlled clinical trial to compare the efficacy of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Miller, PD
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S179 - S179
  • [9] Redistribution of vertebral bone mineral density after transient administration of recombinant human PTH(1-34), LY333334, in monkeys
    Turner, CH
    Hannum, B
    Gurdogan, O
    Clendenon, J
    Sato, M
    [J]. SIROT 99, 1999, : 721 - 724
  • [10] Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis
    Zanchetta, JR
    Bogado, CE
    Ferretti, JL
    Wang, O
    Wilson, MG
    Sato, M
    Gaich, GA
    Dalsky, GP
    Myers, SL
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) : 539 - 543
12345